Evolus, Inc. Common StockEvolus, Inc. Common StockEvolus, Inc. Common Stock

Evolus, Inc. Common Stock

No trades
See on Supercharts
Market capitalization
‪731.21 M‬USD
−1.08USD
‪−61.69 M‬USD
‪202.09 M‬USD
‪48.47 M‬
Beta (1Y)
1.20

About Evolus, Inc. Common Stock

CEO
David Moatazedi
Headquarters
Newport Beach
Website
Employees (FY)
273
Founded
2012
ISIN
US30052C1071
FIGI
BBG005CX4HK8
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EOLS is 12.03 USD — it has increased by 1.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Evolus, Inc. Common Stock stocks are traded under the ticker EOLS.
Evolus, Inc. Common Stock is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Evolus, Inc. Common Stock has a max estimate of 27.00 USD and a min estimate of 16.00 USD.
EOLS earnings for the last quarter are −0.16 USD whereas the estimation was −0.22 USD which accounts for 25.93% surprise. Estimated earnings for the next quarter are −0.12 USD. See more details about Evolus, Inc. Common Stock earnings.
Evolus, Inc. Common Stock revenue for the last quarter amounts to ‪50.00 M‬ USD despite the estimated figure of ‪44.35 M‬ USD. In the next quarter revenue is expected to reach ‪60.19 M‬ USD.
Yes, you can track Evolus, Inc. Common Stock financials in yearly and quarterly reports right on TradingView.
Like other stocks, EOLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evolus, Inc. Common Stock stock right from TradingView charts — choose your broker and connect to your account.
EOLS reached its all-time high on Jun 7, 2018 with the price of 39.50 USD, and its all-time low was 2.85 USD and was reached on Oct 29, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 273.00 employees. See our rating of the largest employees — is Evolus, Inc. Common Stock on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Evolus, Inc. Common Stock EBITDA is ‪−30.24 M‬ USD, and current EBITDA margin is −14.96%. See more stats in Evolus, Inc. Common Stock financial statements.